Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2014 Jan 27.

Published in final edited form as: Liver Int. 2009 Feb 17;29(5):670–677. doi: 10.1111/j.1478-3231.2009.01984.x

Panel A: Mz-ChA-1 cells were pre-incubated for 1 hour with 1 μM EGCG or diluent control prior to treatment with either 0 or 30 μM gemcitabine for 24 hours. Immunocytochemistry was performed for cytochrome C, and images obtained by fluorescence microscopy. Panel B: The fluorescence intensity was measured in cellular cytoplasmic regions in all cells in a randomly selected field using the Metamorph 6.2 image analysis software. The data represents mean ± 95% confidence intervals from 11-13 cells in each group. *p < 0.01.

Panel A: Mz-ChA-1 cells were pre-incubated for 1 hour with 1 μM EGCG or diluent control prior to treatment with either 0 or 30 μM gemcitabine for 24 hours. Immunocytochemistry was performed for cytochrome C, and images obtained by fluorescence microscopy. Panel B: The fluorescence intensity was measured in cellular cytoplasmic regions in all cells in a randomly selected field using the Metamorph 6.2 image analysis software. The data represents mean ± 95% confidence intervals from 11-13 cells in each group. *p < 0.01.